SERUM LEVELS OF MYELOID-RELATED PROTEIN MRP 8/14 (CALPROTECTIN) IN ARMENIAN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER (FMF)


Cite item

Full Text

Abstract

Aim. The determination of serum myeloid-related protein MRP 8/14 (calprotectin) in Armenian patients with FMF before and after treatment with colchicine (including colchicine-resistant patients who don’t respond to 2 mg of colchicine; it patients who don’t respond to 1,5 mg of colchicine, and also responders to different dose of colchicine) and estimation of the response to antiinflammatory therapy. Material and methods. MRP 8/14 serum levels were measured in 80 FMF patients before and after treatment with colchicine and in healthy individuals (n=11) and patients with rheumatoid arthritis RA (n=11) as a control group. Serum MRP 8/14 concentration was measured by ELISA (Enzyme Linked-Immuno-Sorbent-Assay) method using "Bühlmann" kit (Switzerland) in the laboratory with modern equipment. Results. Serum MRP 8/14 concentrations were within a normal ranges in healthy individuals and elevated in patients with FMF and RA. MRP 8/14 serum levels in FMF patients were higher than in RA patients. Serum MRP 8/14 concentrations in FMF patients before colchicines therapy were higher than after treatment. Conclusion. The findings of our study indicate that myeloid-related protein MRP 8/14 is a very sensitive marker of the disease activity and response to antiinflammatory therapy in FMF.

About the authors

Z T Dzhndoyan

M. Geraci Erevan State Medical University

Email: jndoyanzinaida@rambler.ru
Chair of Therapy N 2 Armenia

References

  1. Саркисян Т., Айрапетян А. и др. Перспективы ДНК-диагностики наследственной патологии на примере ПБ. Мед. наука Армении 2001; 41 (2): 31—37.
  2. Hadad J. J. The role of inflammatory cytokines and NF-KB/MAPK signaling pathways in the evolution of familial Mediterranean fever: Current clinical perspective and potential therapeutic approaches. Cell. Immunol. 2009; 260 (1): 6—13.
  3. Murao S. Two calcium-binding proteins, MRP8 and MRP14: a protein complex associated with neutrophil and monocyte activation. Acta Histochem. Cytochem. 1994; 27: 107—116.
  4. Schafer B. W., Heizmann C. W. The S100 family of EF-hand calciumbinding proteins: functions and pathology. Trends Biochem. Sci. 1996; 21: 134—140.
  5. Hessian P. A., Edgeworth J., Hogg N. MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J. Leukoc. Biol. 1993; 53: 197—204.
  6. Teigelkamp S., Bhardwaj R. S., Roth J. et al. Calcium-dependent complex assembly of the myeloic differentiation proteins MRP-8 and MRP-14. J. Biol. Chem. 1991; 266: 13462—13467.
  7. Rammes A., Roth J., Goebeler M. et al. Myeloid-related protein (mRP)8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J. Biol. Chem. 1997; 272: 9496—9502.
  8. Stroncek D. F., Shankar R. A., Skubitz K. M. The subcellular distribution of myeloid-related protein 8 (mRP8) and MRP14 in human neutrophils. J. Trans. Med. 2005; 3: 36.
  9. Odink K., Cerletti N., Bruggen J. et al. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987; 330:80—82.
  10. Bhardwaj R. S., Zotz C., Zwadlo-Klarwasser G. et al. The calcium-binding proteins MRP8 and MRP14 form a membrane-associated heterodimer in a subset of monocytes/macrophages present in acute but absent in chronic inflammatory lesions. Eur. J. Immunol. 1992; 22: 1891—1897.
  11. Eue I., Pietz B., Storck J. et al. Transendothelial migration of 27E10+ human monocytes. Int. Immunol. 2000; 12: 1593—1604.
  12. Frosch M., Strey A., Vogl T. et al. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthri. amd Rheum. 2000; 43: 628—637.
  13. Foell D., Frosch M., Sorg C., Roth J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin. Chim. Acta 2004; 344: 37—51.
  14. Goebeler M., Roth J., Burwinkel F. et al. Expression and complex formation of S100-like proteins MRP8 and MRP14 by macrophages during allograft rejection. Transplantation 1994; 58: 355—361.
  15. Rugtweit J., Brandtzaeg P., Halstensen T. S. et al. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 1994; 35: 669— 674.
  16. Kaden J., May G., Strobelt V. et al. Serum levels of myeloid-related protein 8/14 (mRP 8/14): Dynamics and diagnostic relevance after kidney transplantation. Transplantationsmedizin 2003; 15: 31—39.
  17. Burkhardt K., Radespiel-Tröger M., Rupprecht H. et al. An increase in myeloid-related protein serum levels precedes acute renal allograft rejection. J. Am. Soc. Nephrol. 2001; 12: 1947—1957.
  18. Loser K., Vogl T., Voskort M. et al. The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nature Med. 2010; 16 (6): 713—718.
  19. van Lent P. L. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann. Rheum. Dis. 2008; 67: 1750—1758.
  20. Bogumil T., Rieckmann P., Kubuschok B. et al. Serum levels of macrophage-derived protein MRP8/14 are elevated in active multiple sclerosis. Neurosci. Lett. 1998; 247: 195—197.
  21. Nukui T. S100A8/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes. J. Cell Biochem. 2008; 104: 453—464.
  22. Tajima M. IL-6 dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells. J. Exp. Med. 2008; 205: 1019—1027.
  23. Berntzen H. B., Fagerhol M. K., Ostensen M. et al. The L1 protein as a new indicator of inflammatory activity in patients with juvenile rheumatoid arthritis. J. Rheumatol.1991; 18: 133—138.
  24. Hammer H. B., Kvien T. K., Glennas A., Melby K. A longitudinal study of calprotectin as an inflammatory marker in patients with reactive arthritis. Clin. Exp. Rheumatol. 1995; 13: 59—64.
  25. Haga H. J., Brun J. G., Berntzen H. B. et al. Calprotectin in patients with systemic lupus erythematosus: relation to clinical and laboratory parameters of disease activity. Lupus 1993; 2: 47—50.
  26. Witkowski H., Kallinich T., Keitzer R. et al. The Damage Associated Molecular Pattern (DAMP) molecules and TLR-4 ligands MRP 8/14 in the pathogenesis of familial Mediterranean fever. In: Clinical and experimental rheumatology: The 5-th International Congress on Familial Mediterranean Fever and Systemic Autoinflammatory Diseases. Rome; 2008. 188.
  27. Austermann J. A., Chae J., Kallinic T. et al. The role of Myeloid-related Proteins (mRP) 8 and 14 in the pathophysiology of Familial Mediterranean Fever (FMF). In: Autoinflammation 2010: The 6-th International Conference on FMF and SAID. Amsterdam; 2010. 112—113.

Copyright (c) 2012 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies